pharma · Moderately to Severely Active Rheumatologic Disease · Moderately to Severely Active Ulcerative Colitis · SYRE
Spyre Therapeutics
Spyre Therapeutics events on NovaPharmaNews — congress presentations and investor conference coverage.
Waltham, USA HQ
2023 Founded
110 Employees
Public company Type
SYRE · NYSE Ticker
Company details
- Status
- Public
- HQ
- Waltham, USA
- Founded
- 2023
- Employees
- 110
- Programs
- 8
- Drugs
- 1
- Patents
- 0
Events
Spyre Therapeutics events on NovaPharmaNews — congress presentations and investor conference coverage.
Spyre Therapeutics events on NovaPharmaNews — congress presentations and investor conference coverage.